Peregrine Pharmaceuticals (PPHM) Tops Q3 EPS by 3c

Peregrine Pharmaceuticals (NASDAQ: PPHM) reported Q3 EPS of ($0.04), $0.03 better than the analyst estimate of ($0.07).

For earnings history and earnings-related data on Peregrine Pharmaceuticals (PPHM) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• BofA Securities Reiterates Buy Rating on Micron Technology (MU); Sees $230+ in EPS by FY30
• Cloudastructure reports 164% subscription revenue growth in Q2 2026